Efficacy and Safety of Rosuvastatin Therapy for Children With Familial Hypercholesterolemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Rosuvastatin Therapy for Children With Familial Hypercholesterolemia

Published:2010-03 Issue:11 Volume:55 Page:1121-1126
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Avis Hans J.,Hutten Barbara A.,Gagné Claude,Langslet Gisle,McCrindle Brian W.,Wiegman Albert,Hsia Judith,Kastelein John J.P.,Stein Evan A.

Funder

AstraZeneca, Pfizer, Roche, Novartis, Merck, Merck–Schering-Plough, Isis, Genzyme, and Sanofi-Aventis

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database;Leigh;Ann Hum Genet,2008

2. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia;Marks;Atherosclerosis,2003

3. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia;Wiegman;Lancet,2004

4. Early statin therapy restores endothelial function in children with familial hypercholesterolemia;de Jongh;J Am Coll Cardiol,2002

5. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults;Burke;Stroke,1995

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research trends in lipid-lowering therapies for coronary heart disease combined with hyperlipidemia: a bibliometric study and visual analysis;Frontiers in Pharmacology;2024-05-17

2. Research Progress in the Clinical Treatment of Familial Hypercholesterolemia;Current Medicinal Chemistry;2024-03

3. Statins—Beyond Their Use in Hypercholesterolemia: Focus on the Pediatric Population;Children;2024-01-17

4. Developmental and Inherited Liver Disease;MacSween's Pathology of the Liver;2024

5. The Link between miRNAs and PCKS9 in Atherosclerosis;Current Medicinal Chemistry;2023-11-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3